IL138606A - Solid, quick dissolving cetirizine formulations - Google Patents

Solid, quick dissolving cetirizine formulations

Info

Publication number
IL138606A
IL138606A IL13860699A IL13860699A IL138606A IL 138606 A IL138606 A IL 138606A IL 13860699 A IL13860699 A IL 13860699A IL 13860699 A IL13860699 A IL 13860699A IL 138606 A IL138606 A IL 138606A
Authority
IL
Israel
Prior art keywords
solid
quick dissolving
cetirizine formulations
dissolving cetirizine
formulations
Prior art date
Application number
IL13860699A
Other languages
English (en)
Other versions
IL138606A0 (en
Original Assignee
Viatris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viatris Gmbh filed Critical Viatris Gmbh
Publication of IL138606A0 publication Critical patent/IL138606A0/xx
Publication of IL138606A publication Critical patent/IL138606A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL13860699A 1998-03-31 1999-03-20 Solid, quick dissolving cetirizine formulations IL138606A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19814256A DE19814256A1 (de) 1998-03-31 1998-03-31 Feste, schnellzerfallende Cetirizin-Formulierungen
PCT/DE1999/000799 WO1999049843A1 (de) 1998-03-31 1999-03-20 Feste, schnellzerfallende cetirizin-formulierungen

Publications (2)

Publication Number Publication Date
IL138606A0 IL138606A0 (en) 2001-10-31
IL138606A true IL138606A (en) 2005-07-25

Family

ID=7863014

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13860699A IL138606A (en) 1998-03-31 1999-03-20 Solid, quick dissolving cetirizine formulations

Country Status (31)

Country Link
US (1) US6245353B1 (ko)
EP (1) EP1067904B1 (ko)
JP (1) JP2002509873A (ko)
KR (1) KR100653568B1 (ko)
CN (1) CN1136838C (ko)
AR (1) AR018828A1 (ko)
AT (1) ATE209899T1 (ko)
AU (1) AU750140B2 (ko)
BG (1) BG64741B1 (ko)
BR (1) BR9909233A (ko)
CA (1) CA2326809C (ko)
CY (1) CY1107331T1 (ko)
CZ (1) CZ300704B6 (ko)
DE (2) DE19814256A1 (ko)
DK (1) DK1067904T3 (ko)
ES (1) ES2168013T3 (ko)
HK (1) HK1036217A1 (ko)
HU (1) HU227477B1 (ko)
IL (1) IL138606A (ko)
NO (1) NO329071B1 (ko)
NZ (1) NZ506988A (ko)
PL (1) PL191266B1 (ko)
PT (1) PT1067904E (ko)
RU (1) RU2216318C2 (ko)
SI (1) SI1067904T1 (ko)
SK (1) SK284476B6 (ko)
TR (1) TR200002809T2 (ko)
TW (1) TWI233808B (ko)
UA (1) UA57615C2 (ko)
WO (1) WO1999049843A1 (ko)
ZA (1) ZA200005134B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303700A3 (en) * 2000-07-17 2006-07-28 Astellas Pharma Inc Chuo Ku Pharmaceutical composition improved in peroral absorbability
KR101005648B1 (ko) * 2002-01-15 2011-01-05 유씨비 파쉼 소시에떼아노님 제형
PL372904A1 (en) * 2002-04-04 2005-08-08 Pfizer Products Inc. Palatable chewable tablet
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
US8216610B2 (en) 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US8758816B2 (en) * 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
LT2486942T (lt) 2004-11-24 2019-01-25 Meda Pharmaceuticals Inc. Kompozicijos, apimančios azelastiną ir jų panaudojimo būdai
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
JP2009517346A (ja) 2005-11-28 2009-04-30 イメイジノット ピーティーワイ エルティーディー 治療用化合物の経口送達系
AU2009288006B2 (en) * 2008-09-05 2014-07-17 Mcneil-Ppc, Inc. Method for making cetirizine tablets
WO2010103384A1 (en) * 2009-03-13 2010-09-16 Nucitec S.A. De C.V. Compositions and methods for treatment and prevention of cardiovascular disease
EP2571484A2 (en) * 2010-05-18 2013-03-27 Mahmut Bilgic Effervescent formulations
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
AU2013274378B2 (en) 2012-06-12 2016-06-02 The Procter & Gamble Company Effervescent dosage form
JP5945191B2 (ja) * 2012-08-09 2016-07-05 株式会社ファンケル 口腔内速崩錠
JP6092672B2 (ja) * 2013-03-21 2017-03-08 株式会社ファンケル 口腔内速崩壊性錠剤
KR101591319B1 (ko) * 2013-12-03 2016-02-18 에프엔바이오 주식회사 홍삼 발포정의 제조방법
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
EP3061501A1 (en) 2015-02-27 2016-08-31 Rottapharm Ltd. Composition for the treatment of acne
EP3117825A1 (en) 2015-07-16 2017-01-18 Rottapharm S.p.A. Oral formulation comprising berberine and morus alba extract
CN106109422A (zh) * 2016-07-28 2016-11-16 北京万全德众医药生物技术有限公司 盐酸左西替利嗪泡腾颗粒及其制备方法
US10624921B2 (en) 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
JP2018108950A (ja) * 2016-12-28 2018-07-12 沢井製薬株式会社 レボセチリジン塩酸塩含有口腔内崩壊錠
WO2019099003A2 (en) * 2017-11-15 2019-05-23 Berkeley Nox Limited Novel dietary supplements
PT3799864T (pt) 2019-10-02 2023-05-25 Intas Pharmaceuticals Ltd Composições farmacêuticas sólidas efervescentes essencialmente isentas de sódio

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4792448A (en) * 1987-06-11 1988-12-20 Pfizer Inc. Generic zero order controlled drug delivery system
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5178878A (en) 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
RU2145219C1 (ru) * 1991-05-13 2000-02-10 Дзе Бутс Компани ПЛС Фармацевтическая композиция, содержащая s(-)-2-(4-изобутилфенил)пропионат натрия, способ получения натриевой соли энантиомера 2-(4-изобутилфенил)пропионовой кислоты, s(-)-2-(4-изобутилфенил)пропионат натрия дигидрат
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
EP0662840A1 (en) * 1992-10-09 1995-07-19 The Procter & Gamble Company Pharmaceutical compositions and methods for treating cold symptoms
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
FR2698788B1 (fr) * 1992-12-09 1995-03-03 Union Pharma Scient Appl Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
ATE140621T1 (de) * 1993-04-15 1996-08-15 Gergely Gerhard Brausesystem mit einem alkali- und/oder metallempfindlichen, pharmazeutischen wirkstoff, und verfahren zur herstellung
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions

Also Published As

Publication number Publication date
DK1067904T3 (da) 2002-04-02
US6245353B1 (en) 2001-06-12
CZ20003481A3 (en) 2001-05-16
SI1067904T1 (en) 2002-04-30
PL343199A1 (en) 2001-07-30
DE59900501D1 (de) 2002-01-17
RU2216318C2 (ru) 2003-11-20
WO1999049843A1 (de) 1999-10-07
NO20004722L (no) 2000-09-21
PT1067904E (pt) 2002-05-31
KR20010034718A (ko) 2001-04-25
EP1067904A1 (de) 2001-01-17
KR100653568B1 (ko) 2006-12-05
BG64741B1 (bg) 2006-02-28
JP2002509873A (ja) 2002-04-02
SK14312000A3 (sk) 2001-07-10
PL191266B1 (pl) 2006-04-28
SK284476B6 (sk) 2005-04-01
NO20004722D0 (no) 2000-09-21
DE19814256A1 (de) 1999-10-07
CY1107331T1 (el) 2012-12-19
ZA200005134B (en) 2000-12-21
CN1136838C (zh) 2004-02-04
HK1036217A1 (en) 2001-12-28
TWI233808B (en) 2005-06-11
AU3925399A (en) 1999-10-18
EP1067904B1 (de) 2001-12-05
AU750140B2 (en) 2002-07-11
BG104843A (en) 2001-07-31
NZ506988A (en) 2002-05-31
HUP0102676A3 (en) 2002-12-28
CA2326809C (en) 2008-11-18
ES2168013T3 (es) 2002-05-16
CZ300704B6 (cs) 2009-07-22
BR9909233A (pt) 2000-11-28
CN1295464A (zh) 2001-05-16
AR018828A1 (es) 2001-12-12
ATE209899T1 (de) 2001-12-15
NO329071B1 (no) 2010-08-16
TR200002809T2 (tr) 2000-12-21
HU227477B1 (en) 2011-07-28
IL138606A0 (en) 2001-10-31
CA2326809A1 (en) 1999-10-07
UA57615C2 (uk) 2003-06-16
HUP0102676A2 (hu) 2001-11-28

Similar Documents

Publication Publication Date Title
IL138606A (en) Solid, quick dissolving cetirizine formulations
HK1044284A1 (en) Sustained release ranolazine formulations.
ZA993338B (en) Pharmaceutical formulations.
HK1042653A1 (en) External preparation.
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
PL343021A1 (en) Formulations
ZA200108304B (en) Agrochemical formulations.
ZA997174B (en) Antiparasitic formulations.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
HK1049798A1 (en) Solid lipid formulations.
HK1038884A1 (en) Medicinal compositions.
HK1051199A1 (en) New phenylpiperazines.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
MXPA01012478A (es) Formulaciones farmaceuticas mejoradas.
ZA200005510B (en) Pharmaceutical composition.
HK1034298A1 (en) Scaffolding.
HK1046642A1 (en) Novel diphenylethylene compounds.
HK1040488A1 (en) Pharmaceutical formulations.
ZA9810637B (en) Formulations comprising dissolved paroxetine.
ZA993473B (en) Pellet formulations.
HK1044117A1 (en) Pharmaceutical composition.
HK1036770A1 (en) Kneader.
ZA99890B (en) Pharmaceutical compositions.
ZA994697B (en) Pharmaceutical formulation.
GB9903377D0 (en) Amphibious-tricycle (amphi-trike)

Legal Events

Date Code Title Description
HP Change in proprietorship
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees